Horizon Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.61M | Sell |
14,244
-3,138
| -18% | -$578K | 0.03% | 418 |
|
|
2025
Q4 | $3.06M | Sell |
17,382
-43,667
| -72% | -$7.13M | 0.04% | 360 |
|
|
2025
Q3 | $8.55M | Sell |
61,049
-217
| -0.4% | -$29.3K | 0.11% | 150 |
|
|
2025
Q2 | $7.69M | Buy |
61,266
+59,108
| +2,739% | +$7.36M | 0.12% | 137 |
|
|
2025
Q1 | $295K | Buy |
2,158
+117
| +6% | +$16.7K | 0.01% | 468 |
|
|
2024
Q4 | $312K | Sell |
2,041
-397
| -16% | -$67K | 0.01% | 448 |
|
|
2024
Q3 | $473K | Sell |
2,438
-260
| -10% | -$54.4K | 0.01% | 376 |
|
|
2024
Q2 | $625K | Buy |
2,698
+8
| +0.3% | +$1.74K | 0.02% | 330 |
|
|
2024
Q1 | $580K | Buy |
2,690
+139
| +5% | +$32.6K | 0.02% | 338 |
|
|
2023
Q4 | $660K | Buy |
2,551
+52
| +2% | +$12.8K | 0.02% | 288 |
|
|
2023
Q3 | $642K | Sell |
2,499
-26
| -1% | -$6.95K | 0.02% | 235 |
|
|
2023
Q2 | $719K | Buy |
2,525
+18
| +0.7% | +$5.36K | 0.02% | 226 |
|
|
2023
Q1 | $697K | Sell |
2,507
-927
| -27% | -$256K | 0.02% | 229 |
|
|
2022
Q4 | $951K | Sell |
3,434
-3,371
| -50% | -$952K | 0.03% | 230 |
|
|
2022
Q3 | $1.82M | Buy |
6,805
+5,081
| +295% | +$1.08M | 0.06% | 121 |
|
|
2022
Q2 | $352K | Sell |
1,724
-7,970
| -82% | -$1.63M | 0.01% | 345 |
|
|
2022
Q1 | $2.04M | Buy |
9,694
+1,600
| +20% | +$348K | 0.06% | 145 |
|
|
2021
Q4 | $1.94M | Sell |
8,094
-248
| -3% | -$63.8K | 0.06% | 146 |
|
|
2021
Q3 | $2.36M | Buy |
8,342
+489
| +6% | +$160K | 0.06% | 139 |
|
|
2021
Q2 | $2.72M | Buy |
7,853
+5,551
| +241% | +$1.68M | 0.08% | 121 |
|
|
2021
Q1 | $644K | Buy |
+2,302
| New | +$621K | 0.02% | 261 |
|
|
2020
Q4 | – | Sell |
-5,942
| Closed | -$1.69M | – | 114 |
|
|
2020
Q3 | $1.69M | Sell |
5,942
-4,984
| -46% | -$1.39M | 0.06% | 139 |
|
|
2020
Q2 | $2.92M | Buy |
10,926
+8,693
| +389% | +$2.61M | 0.07% | 124 |
|
|
2020
Q1 | $706K | Sell |
2,233
-1,426
| -39% | -$433K | 0.03% | 149 |
|
|
2019
Q4 | $1.09M | Buy |
3,659
+2,388
| +188% | +$663K | 0.05% | 156 |
|
|
2019
Q3 | $296K | Sell |
1,271
-99
| -7% | -$23.1K | 0.01% | 249 |
|
|
2019
Q2 | $320K | Buy |
1,370
+276
| +25% | +$63.7K | 0.01% | 362 |
|
|
2019
Q1 | $259K | Buy |
+1,094
| New | +$344K | 0.01% | 303 |
|
|
2016
Q4 | – | Sell |
-1,610
| Closed | -$504K | – | 161 |
|
|
2016
Q3 | $504K | Buy |
+1,610
| New | +$477K | 0.03% | 78 |
|
|
2016
Q2 | – | Sell |
-1,933
| Closed | -$503K | – | 107 |
|
|
2016
Q1 | $503K | Buy |
+1,933
| New | +$511K | 0.04% | 69 |
|
Other funds holding BIIB
VCM
VPM
Horizon Investments's BIIB Position: Q1 2026 in Review
Horizon Investments reduced its Biogen (BIIB) stake by 18% in Q1 2026, selling an estimated $578K and leaving 14,244 shares worth $2.61M. The position accounts for 0.03% of the portfolio, ranked #418.
Horizon Investments first reported a position in BIIB in Q1 2016 and has held it in 30 quarters since. The position peaked at $8.55M in Q3 2025. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Horizon Investments held 14,244 shares of Biogen worth $2.61M as of Q1 2026.
- Horizon Investments sold 3,138 Biogen shares in Q1 2026, an estimated $578K.
- Biogen made up 0.03% of Horizon Investments's portfolio in Q1 2026, its #418 holding.
- Horizon Investments first reported a position in Biogen in Q1 2016 and has held it in 30 quarters since.
- Horizon Investments's Biogen position peaked at $8.55M in Q3 2025.
- 1,008 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.